{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T11:15:06Z","timestamp":1789730106449,"version":"4.0.1"},"reference-count":73,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.neurol.2025.03.005","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T10:44:08Z","timestamp":1743590648000},"page":"382-390","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Epilepsy and Alzheimer disease: New insights and perspectives"],"prefix":"10.1016","volume":"181","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2080-8253","authenticated-orcid":false,"given":"Sophie","family":"Dupont","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.neurol.2025.03.005_bib0370","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41582-024-00932-4","article-title":"Epilepsy and epileptiform activity in late-onset Alzheimer disease: clinical and pathophysiological advances, gaps and conundrums","volume":"20","author":"Kamondi","year":"2024","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.neurol.2025.03.005_bib0375","doi-asserted-by":"crossref","first-page":"109640","DOI":"10.1016\/j.yebeh.2024.109640","article-title":"The crosstalk between epilepsy and dementia: a systematic review and meta-analysis","volume":"152","author":"Chen","year":"2024","journal-title":"Epilepsy Behav"},{"issue":"3","key":"10.1016\/j.neurol.2025.03.005_bib0380","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.3233\/JAD-170925","article-title":"Prevalence, semiology, and risk factors of epilepsy in Alzheimer's disease: an ambulatory EEG study","volume":"63","author":"Horv\u00e1th","year":"2018","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2025.03.005_bib0385","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.seizure.2018.03.014","article-title":"Epilepsy in neuropathologically verified Alzheimer's disease","volume":"58","author":"Rauramaa","year":"2018","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.neurol.2025.03.005_bib0390","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/ene.15089","article-title":"Seizure prevalence in neurodegenerative diseases\u00a0\u2013\u00a0a study of autopsy proven cases","volume":"29","author":"V\u00f6glein","year":"2022","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2025.03.005_bib0395","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/ene.14043","article-title":"Increased risk of epilepsy in patients registered in the Swedish Dementia Registry","volume":"27","author":"Zelano","year":"2020","journal-title":"Eur J Neurol"},{"key":"10.1016\/j.neurol.2025.03.005_bib0400","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.seizure.2020.09.001","article-title":"Risk of epilepsy diagnosis after a first unprovoked seizure in dementia","volume":"82","author":"Mahamud","year":"2020","journal-title":"Seizure"},{"issue":"9","key":"10.1016\/j.neurol.2025.03.005_bib0405","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1212\/WNL.0000000000003048","article-title":"Seizures in dominantly inherited Alzheimer disease","volume":"87","author":"Zarea","year":"2016","journal-title":"Neurology"},{"issue":"6534","key":"10.1016\/j.neurol.2025.03.005_bib0410","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/375754a0","article-title":"Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease","volume":"375","author":"Sherrington","year":"1995","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.neurol.2025.03.005_bib0415","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1001\/jamaneurol.2020.0187","article-title":"Association of late-onset unprovoked seizures of unknown etiology with the risk of developing dementia in older veterans","volume":"77","author":"Keret","year":"2020","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.neurol.2025.03.005_bib0420","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/epd2.20199","article-title":"Point prevalence of epilepsy in dementia: a \u201creal-world\u201d estimate","volume":"26","author":"Muroni","year":"2024","journal-title":"Epileptic Disord"},{"issue":"4","key":"10.1016\/j.neurol.2025.03.005_bib0425","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.3233\/JAD-231309","article-title":"Incidence and risk factors epilepsy in patients with dementia: a population-based study using regional healthcare databases in Umbria","volume":"98","author":"Costa","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"6","key":"10.1016\/j.neurol.2025.03.005_bib0430","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.neurol.2020.04.011","article-title":"Getting older with chronic temporal lobe epilepsy: what memory profile?","volume":"176","author":"Samson","year":"2020","journal-title":"Rev Neurol (Paris)"},{"issue":"Pt 10","key":"10.1016\/j.neurol.2025.03.005_bib0435","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.1093\/brain\/awp182","article-title":"Chronic temporal lobe epilepsy: a neurodevelopmental or progressively dementing disease?","volume":"132","author":"Helmstaedter","year":"2009","journal-title":"Brain"},{"issue":"8","key":"10.1016\/j.neurol.2025.03.005_bib0440","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1212\/WNL.0b013e3181eee3f0","article-title":"Cognitive consequences of childhood-onset temporal lobe epilepsy across the adult lifespan","volume":"75","author":"Baxendale","year":"2010","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.neurol.2025.03.005_bib0445","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1528-1167.2007.01435.x","article-title":"Growing old with epilepsy: the neglected issue of cognitive and brain health in aging and elder persons with chronic epilepsy","volume":"49","author":"Hermann","year":"2008","journal-title":"Epilepsia"},{"issue":"1","key":"10.1016\/j.neurol.2025.03.005_bib0450","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-170031","article-title":"Relative incidence of seizures and myoclonus in Alzheimer's disease, dementia with Lewy bodies, and frontotemporal dementia","volume":"60","author":"Beagle","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2025.03.005_bib0455","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1212\/WNL.36.9.1226","article-title":"Seizures and myoclonus in patients with Alzheimer's disease","volume":"36","author":"HauserWA","year":"1986","journal-title":"Neurology"},{"issue":"4","key":"10.1016\/j.neurol.2025.03.005_bib0460","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1053\/seiz.2000.0500","article-title":"Late-onset myoclonic epilepsy in Down's syndrome (LOMEDS)","volume":"10","author":"M\u00f6ller","year":"2001","journal-title":"Seizure"},{"key":"10.1016\/j.neurol.2025.03.005_bib0465","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.seizure.2023.05.017","article-title":"Diagnosis and treatment of late-onset myoclonic epilepsy in Down syndrome (LOMEDS): a systematic review with individual patients\u2019 data analysis","volume":"109","author":"Corniello","year":"2023","journal-title":"Seizure"},{"key":"10.1016\/j.neurol.2025.03.005_bib0470","doi-asserted-by":"crossref","first-page":"101478","DOI":"10.1016\/j.arr.2021.101478","article-title":"Risk of seizures and subclinical epileptiform activity in patients with dementia: a systematic review and meta-analysis","volume":"72","author":"Zhao","year":"2021","journal-title":"Ageing Res Rev"},{"issue":"6","key":"10.1016\/j.neurol.2025.03.005_bib0475","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/ana.24794","article-title":"Incidence and impact of subclinical epileptiform activity in Alzheimer's disease","volume":"80","author":"Vossel","year":"2016","journal-title":"Ann Neurol"},{"issue":"8","key":"10.1016\/j.neurol.2025.03.005_bib0480","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.clinph.2021.03.050","article-title":"Subclinical epileptiform activity accelerates the progression of Alzheimer's disease: a long-term EEG study","volume":"132","author":"Horvath","year":"2021","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.neurol.2025.03.005_bib0485","doi-asserted-by":"crossref","first-page":"106149","DOI":"10.1016\/j.nbd.2023.106149","article-title":"Detection of subclinical epileptiform discharges in Alzheimer's disease using long-term outpatient EEG monitoring","volume":"183","author":"Musaeus","year":"2023","journal-title":"Neurobiol Dis"},{"issue":"4","key":"10.1016\/j.neurol.2025.03.005_bib0490","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/epi.12045","article-title":"Seizures in patients with Alzheimer's disease or vascular dementia: a population-based nested case-control analysis","volume":"54","author":"Imfeld","year":"2013","journal-title":"Epilepsia"},{"issue":"3","key":"10.1016\/j.neurol.2025.03.005_bib0495","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.3233\/JAD-150096","article-title":"Epileptic prodromal Alzheimer's disease, a retrospective study of 13 new cases: expanding the spectrum of Alzheimer's disease to an epileptic variant?","volume":"52","author":"Cretin","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.neurol.2025.03.005_bib0500","first-page":"S1059","article-title":"Epileptic variant in the spectrum of Alzheimer's disease \u2013 practical implications","volume":"21","author":"Cretin","year":"2024","journal-title":"Seizure"},{"issue":"1","key":"10.1016\/j.neurol.2025.03.005_bib0505","first-page":"478","article-title":"Epileptic activity on foramen ovale electrodes is associated with sleep and tau pathology in Alzheimer's disease","volume":"24","author":"Devulder","year":"2024","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.neurol.2025.03.005_bib0510","doi-asserted-by":"crossref","first-page":"e209920","DOI":"10.1212\/WNL.0000000000209920","article-title":"Association of seizure foci and location of Tau and amyloid deposition and brain atrophy in patients with Alzheimer disease and seizures","volume":"103","author":"Lam","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.03.005_bib0515","first-page":"S1059","article-title":"Late-onset epilepsy clinic: from clinical diagnostics to biomarkers","volume":"26","author":"Punia","year":"2024","journal-title":"Seizure"},{"issue":"6453","key":"10.1016\/j.neurol.2025.03.005_bib0520","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1126\/science.aay0198","article-title":"A vicious cycle of \u03b2 amyloid-dependent neuronal hyperactivation","volume":"365","author":"Zott","year":"2019","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.neurol.2025.03.005_bib0525","doi-asserted-by":"crossref","first-page":"13592","DOI":"10.1038\/s41598-019-50018-1","article-title":"Amyloid \u03b2-induced upregulation of Nav1.6 underlies neuronal hyperactivity in Tg2576 Alzheimer's disease mouse model","volume":"9","author":"Ciccone","year":"2019","journal-title":"Sci Rep"},{"issue":"20","key":"10.1016\/j.neurol.2025.03.005_bib0530","doi-asserted-by":"crossref","first-page":"11106","DOI":"10.3390\/ijms222011106","article-title":"The expression and localisation of G-protein-coupled inwardly rectifying potassium (GIRK) channels is differentially altered in the hippocampus of two mouse models of Alzheimer's disease","volume":"22","author":"Alfaro-Ruiz","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.neurol.2025.03.005_bib0535","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.neurol.2025.03.005_bib0540","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.tins.2012.11.008","article-title":"Glia and epilepsy: excitability and inflammation","volume":"36","author":"Devinsky","year":"2013","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neurol.2025.03.005_bib0545","doi-asserted-by":"crossref","first-page":"1441996","DOI":"10.3389\/fneur.2024.1441996","article-title":"Editorial: epilepsy and Alzheimer's disease: shared pathology, clinical presentations, and targets for treatment","volume":"15","author":"Leeman-Markowski","year":"2024","journal-title":"Front Neurol"},{"key":"10.1016\/j.neurol.2025.03.005_bib0550","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.neurobiolaging.2018.09.006","article-title":"Alzheimer's disease and late-onset epilepsy of unknown origin: two faces of beta amyloid pathology","volume":"73","author":"Costa","year":"2019","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neurol.2025.03.005_bib0555","doi-asserted-by":"crossref","first-page":"fcac210","DOI":"10.1093\/braincomms\/fcac210","article-title":"CSF biomarkers in patients with epilepsy in Alzheimer's disease: a nation-wide study","volume":"4","author":"Banote","year":"2022","journal-title":"Brain Commun"},{"issue":"1","key":"10.1016\/j.neurol.2025.03.005_bib0560","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1093\/brain\/awaa397","article-title":"Atrophy and cognitive profiles in older adults with temporal lobe epilepsy are similar to mild cognitive impairment","volume":"144","author":"Kaestner","year":"2021","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neurol.2025.03.005_bib0565","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1093\/brain\/awy022","article-title":"Cognition and dementia in older patients with epilepsy","volume":"141","author":"Sen","year":"2018","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.03.005_bib0570","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1474-4422(04)00767-7","article-title":"An active and socially integrated lifestyle in late life might protect against dementia","volume":"3","author":"Fratiglioni","year":"2004","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neurol.2025.03.005_bib0575","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.brainresrev.2005.11.007","article-title":"Lipid metabolism in cognitive decline and dementia","volume":"51","author":"Panza","year":"2006","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.neurol.2025.03.005_bib0580","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1212\/01.WNL.0000158281.08946.68","article-title":"Serum inflammatory proteins and cognitive decline in older persons","volume":"64","author":"Dik","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2025.03.005_bib0585","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.yebeh.2014.07.003","article-title":"Atherosclerosis in epilepsy: its causes and implications","volume":"41","author":"Hamed","year":"2014","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.neurol.2025.03.005_bib0590","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/epi.13187","article-title":"Childhood-onset epilepsy five decades later. A prospective population-based cohort study","volume":"56","author":"Sillanp\u00e4\u00e4","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.neurol.2025.03.005_bib0595","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.brainresbull.2020.04.009","article-title":"Epilepsy and Alzheimer's disease: potential mechanisms for an association","volume":"160","author":"Giorgi","year":"2020","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neurol.2025.03.005_bib0600","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12974-018-1192-7","article-title":"The role of inflammation in the development of epilepsy","volume":"15","author":"Rana","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"19","key":"10.1016\/j.neurol.2025.03.005_bib0605","doi-asserted-by":"crossref","first-page":"e113246","DOI":"10.15252\/embj.2022113246","article-title":"Microglia-synapse engulfment via PtdSer-TREM2 ameliorates neuronal hyperactivity in Alzheimer's disease models","volume":"42","author":"Rueda-Carrasco","year":"2023","journal-title":"EMBO J"},{"key":"10.1016\/j.neurol.2025.03.005_bib0610","doi-asserted-by":"crossref","first-page":"106263","DOI":"10.1016\/j.nbd.2023.106263","article-title":"Alzheimer risk-increasing TREM2 variant causes aberrant cortical synapse density and promotes network hyperexcitability in mouse models","volume":"186","author":"Das","year":"2023","journal-title":"Neurobiol Dis"},{"issue":"5","key":"10.1016\/j.neurol.2025.03.005_bib0615","doi-asserted-by":"crossref","first-page":"fcae327","DOI":"10.1093\/braincomms\/fcae327","article-title":"Enhanced Fyn-tau and NR2B-PSD95 interactions in epileptic foci in experimental models and human epilepsy","volume":"6","author":"Putra","year":"2024","journal-title":"Brain Commun"},{"issue":"6","key":"10.1016\/j.neurol.2025.03.005_bib0620","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1093\/brain\/awae126","article-title":"Seizures exacerbate excitatory: inhibitory imbalance in Alzheimer's disease and 5XFAD mice","volume":"147","author":"Barbour","year":"2024","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neurol.2025.03.005_bib0625","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1093\/brain\/awae146","article-title":"Targeting excitatory:inhibitory network imbalance in Alzheimer's disease","volume":"147","author":"Blum","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2025.03.005_bib0630","doi-asserted-by":"crossref","first-page":"1260523","DOI":"10.3389\/fneur.2023.1260523","article-title":"Overlapping and distinct phenotypic profiles in Alzheimer's disease and late onset epilepsy: a biologically-based approach","volume":"14","author":"Liu","year":"2024","journal-title":"Front Neurol"},{"issue":"1","key":"10.1016\/j.neurol.2025.03.005_bib0635","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1093\/brain\/awae207","article-title":"Late-onset temporal lobe epilepsy: insights from brain atrophy and Alzheimer's disease biomarkers","volume":"148","author":"Ballerini","year":"2025","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.neurol.2025.03.005_bib0640","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1177\/13872877241295407","article-title":"Documentation of prodromal features and risk factors of dementia disease in primary care practice","volume":"102","author":"Michalowsky","year":"2024","journal-title":"J Alzheimers Dis"},{"issue":"18","key":"10.1016\/j.neurol.2025.03.005_bib0645","doi-asserted-by":"crossref","first-page":"10228","DOI":"10.3390\/ijms251810228","article-title":"Synergistic effect between the APOE \u025b4 allele with genetic variants of GSK3B and MAPT: differential profile between refractory epilepsy and Alzheimer disease","volume":"25","author":"Toral-Rios","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.neurol.2025.03.005_bib0650","doi-asserted-by":"crossref","first-page":"e399","DOI":"10.1212\/WNL.0000000000207423","article-title":"Alzheimer disease and epilepsy: a Mendelian randomization study","volume":"101","author":"Fang","year":"2023","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.neurol.2025.03.005_bib0655","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1007\/s12035-024-03955-6","article-title":"Association between neurodegenerative diseases and an increased risk of epilepsy based on single nucleotide polymorphisms: a Mendelian randomization study","volume":"61","author":"Ouyang","year":"2024","journal-title":"Mol Neurobiol"},{"issue":"1","key":"10.1016\/j.neurol.2025.03.005_bib0660","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11845-023-03447-x","article-title":"Identification of common core ion channel genes in epilepsy and Alzheimer's disease","volume":"193","author":"Tang","year":"2024","journal-title":"Ir J Med Sci"},{"issue":"2","key":"10.1016\/j.neurol.2025.03.005_bib0665","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3233\/JAD-215154","article-title":"Epileptic seizures in Alzheimer's disease: what are the implications of SANAD II?","volume":"85","author":"Larner","year":"2022","journal-title":"J Alzheimers Dis"},{"issue":"11","key":"10.1016\/j.neurol.2025.03.005_bib0670","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s40263-016-0384-x","article-title":"Synaptic vesicle glycoprotein 2A ligands in the treatment of epilepsy and beyond","volume":"30","author":"L\u00f6scher","year":"2016","journal-title":"CNS Drugs"},{"issue":"42","key":"10.1016\/j.neurol.2025.03.005_bib0675","doi-asserted-by":"crossref","first-page":"E2895","DOI":"10.1073\/pnas.1121081109","article-title":"Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model","volume":"109","author":"Sanchez","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"10.1016\/j.neurol.2025.03.005_bib0680","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1001\/jamaneurol.2021.3310","article-title":"Effect of levetiracetam on cognition in patients with Alzheimer disease with and without epileptiform activity: a randomized clinical trial","volume":"78","author":"Vossel","year":"2021","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.neurol.2025.03.005_bib0685","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3390\/brainsci11091211","article-title":"Understanding the modulatory effects of cannabidiol on Alzheimer's disease","volume":"11","author":"Xiong","year":"2021","journal-title":"Brain Sci"},{"issue":"47","key":"10.1016\/j.neurol.2025.03.005_bib0690","doi-asserted-by":"crossref","first-page":"28540","DOI":"10.1074\/jbc.M115.652586","article-title":"Ethosuximide induces hippocampal neurogenesis and reverses cognitive deficits in an amyloid-\u03b2 toxin-induced Alzheimer rat model via the phosphatidylinositol 3-kinase (PI3K)\/Akt\/Wnt\/\u03b2-Catenin pathway","volume":"290","author":"Tiwari","year":"2015","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.neurol.2025.03.005_bib0695","doi-asserted-by":"crossref","first-page":"189","DOI":"10.4103\/1673-5374.343888","article-title":"Lamotrigine protects against cognitive deficits, synapse and nerve cell damage, and hallmark neuropathologies in a mouse model of Alzheimer's disease","volume":"18","author":"Fu","year":"2023","journal-title":"Neural Regen Res"},{"issue":"11","key":"10.1016\/j.neurol.2025.03.005_bib0700","doi-asserted-by":"crossref","first-page":"e23252","DOI":"10.1096\/fj.202300837R","article-title":"Acute inhibition of AMPA receptors by perampanel reduces amyloid \u03b2-protein levels by suppressing \u03b2-cleavage of APP in Alzheimer's disease models","volume":"37","author":"Ueda","year":"2023","journal-title":"FASEB J"},{"issue":"13","key":"10.1016\/j.neurol.2025.03.005_bib0705","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.3390\/jcm13133879","article-title":"Alzheimer's disease and epilepsy: exploring shared pathways and promising biomarkers for future treatments","volume":"13","author":"Kalyvas","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.neurol.2025.03.005_bib0710","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.3233\/JAD-230059","article-title":"Neuroinflammation: a common pathway in Alzheimer's disease and epilepsy","volume":"94","author":"Liew","year":"2023","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.neurol.2025.03.005_bib0715","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/epd2.20202","article-title":"Memantine's double duty? Investigating its impact on epilepsy control in Alzheimer's disease","volume":"26","author":"Rayala","year":"2024","journal-title":"Epileptic Disord"},{"issue":"3","key":"10.1016\/j.neurol.2025.03.005_bib0720","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/jnr.23500","article-title":"N-methyl-D-aspartate receptor channel blockers prevent pentylenetetrazole-induced convulsions and morphological changes in rat brain neurons","volume":"93","author":"Zaitsev","year":"2015","journal-title":"J Neurosci Res"},{"issue":"3","key":"10.1016\/j.neurol.2025.03.005_bib0725","doi-asserted-by":"crossref","first-page":"e70001","DOI":"10.1002\/trc2.70001","article-title":"Anti-epileptic drug use and subsequent degenerative dementia occurrence","volume":"10","author":"Ikegaya","year":"2024","journal-title":"Alzheimers Dement (N Y)"},{"issue":"2","key":"10.1016\/j.neurol.2025.03.005_bib0730","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/ana.27125","article-title":"Association of seizure control with mortality, cognition, and function in people with dementia","volume":"97","author":"Zawar","year":"2025","journal-title":"Ann Neurol"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725004862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378725004862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T16:27:51Z","timestamp":1746808071000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378725004862"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":73,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0035378725004862"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2025.03.005","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epilepsy and Alzheimer disease: New insights and perspectives","name":"articletitle","label":"Article Title"},{"value":"Revue Neurologique","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurol.2025.03.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}